Na Song, Jinglei Qu, Ying Chen, Danni Li, Xiujuan Qu. "Camrelizumab plus rivoceranib as first-line maintenance therapy after camrelizumab-chemo induction in advanced esophageal squamous cell carcinoma: A prospective, single-arm, phase II clinical trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.19_suppl.tps158